Resveratrol blocks high glucose–induced mitochondrial reactive oxygen species production in bovine aortic endothelial cells: role of phase 2 enzyme induction?
- 1 April 2008
- journal article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 10 (4), 347-349
- https://doi.org/10.1111/j.1463-1326.2008.00866.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stressPharmacological Research, 2005
- Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cellsBiochemical and Biophysical Research Communications, 2005
- Cardiovascular Protective Effects of ResveratrolCardiovascular Drug Reviews, 2004
- Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injuryEuropean Journal of Pharmacology, 2004
- A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrolCarcinogenesis: Integrative Cancer Research, 2001
- Antioxidant vitamins and prevention of cardiovascular disease: Epidemiological and clinical trial dataLipids, 2001
- Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damageNature, 2000
- Oxidative Stress and Diabetic Vascular ComplicationsDiabetes Care, 1996